Junpei Sanada

Comparison of the effects of three kinds of glucose‐lowering drugs on non‐alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, open‐label, three‐arm, active control study

Tomoe Kinoshita, Masashi Shimoda, Koji Nakashima et al. · Journal of Diabetes Investigation · 2020 · 102 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Imeglimin exerts favorable effects on pancreatic β-cells by improving morphology in mitochondria and increasing the number of insulin granules

Junpei Sanada, Atsushi Obata, Yoshiro Fushimi et al. · Scientific Reports · 2022 · 44 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Dulaglutide exerts beneficial anti atherosclerotic effects in ApoE knockout mice with diabetes: the earlier, the better

Junpei Sanada, Atsushi Obata, Yoshiyuki Obata et al. · Scientific Reports · 2021 · 42 citations · Full text

Medicine, Cardiology, Pharmacology +16

Association of GA/HbA1c ratio and cognitive impairment in subjects with type 2 diabetes mellitus

Tomoe Kinoshita, Masashi Shimoda, Junpei Sanada et al. · Journal of Diabetes and its Complications · 2016 · 32 citations

Medicine, Neurology, Diabetology +13

Comparison of HbA1c levels and body mass index for prevention of diabetic kidney disease: A retrospective longitudinal study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus

Shuhei Nakanishi, Hidenori Hirukawa, Masashi Shimoda et al. · Diabetes Research and Clinical Practice · 2019 · 23 citations · Full text

Medicine, Internal Medicine, Nephrology +13